Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma	Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Not yet recruiting	Phase 2	2025-04-06		NCT06045195

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Cologne	43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
1st Department of Medicine, Cologne University Hospital	Cologne	Germany	4

Clinical trials